期刊文献+

胱抑素C国家标准物质的研制 被引量:4

Establishment of first national standard of Cystatin C
原文传递
导出
摘要 目的 研制胱抑素C标准物质.方法 前瞻性研究.以重组人胱抑素C抗原为原料进行稀释、无菌分装制得;在全自动生化分析仪上完成均匀性和稳定性测试;由6家实验室在严格规定的试验条件下,采用经广泛认可的免疫比浊分析法,与国际标物ERM-DA471进行比较,得到所研制标物的量值;按照文件EP14《基质效应的评价》测试该候选标物及其生理盐水稀释液的互换性.采用Excel 2007软件分析数据.结果 候选标物具有较好的免疫活性,均匀性和稳定性良好,2~8℃密封保存可稳定6个月,常温和37℃密封保存可稳定30 d,开瓶后2~8℃冷藏可稳定30 d,最终定值结果为(4.47 ±0.25) mg/L(包含因子k=2),该候选标物或其生理盐水稀释液在所评估的10个常规测试系统上具有互换性.结论 该标准物质符合国家二级标准物质要求,可用于该项目的质量评价和控制. Objective To establish the first national standard of Cystatin C. Methods The candidate standard was prepared from human recombinant Cystatin C, diluted and dispensed aseptically. Homogeneity and stability study were carried out on the automated biochemical analyzer. The target value was assigned by six laboratories using widely recognized immumoassay under strict conditions, and traceable to ERM-DA471. Commutabilities of the candidate standard and its saline dilutions were evaluated according to EP14-Evaluation of Matrix Effects. Excel 2007 was used to analyze the results. Results The preparation had good immunological activity and was proved to be homogeneous and stable (6 months sealed at 2 - 8 ℃, 30 days sealed at room temperature and 37 ℃, 30 days open-vial at 2 - 8 ℃ ). The assigned value of the preparation was ( 4.47 ± 0. 25 ) mg/L ( coverage factor k = 2 ). The candidate standard and/or its saline dilutions have commutability on the 10 evaluated systems. Conclusion The preparation meets the requirements of national secondary standard and could be used in quality control and evaluation of Cystatin C assays in China.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2013年第10期942-946,共5页 Chinese Journal of Laboratory Medicine
基金 北京市科技计划资助项目(Z101102052610002)
关键词 胱抑素C 试剂盒 诊断 参考标准 免疫测定 Cystatin C Reagent kits, diagnostic Reference standards Immunoassay
  • 相关文献

参考文献15

  • 1Kazanm J J, Kutsuwada K, Ataka K, et al. Serum Cystatin C reliably detects renal disfunction in patients with various renal diseases. Nephron, 2002, 91: 13-20.
  • 2Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis, 2002, 40 : 221-226.
  • 3尹志农,王俊文,周新.原发性Ⅱb型高脂血症尿酸和炎性因子及其血清胱抑素C水平观察[J].中华检验医学杂志,2007,30(10):1131-1133. 被引量:8
  • 4李村淑,周兴虎,孙英贤.高血压患者动态动脉僵硬指数与血清胱抑素C关联性观察[J].中华检验医学杂志,2012,35(6):568-570. 被引量:5
  • 5国秀芝,秦岩,郑可,邱玲,崔巍,程歆琦,寿玮龄,朱岩,邸茜,秦绪珍,韩惠娟,权国强,俸家富,李雪梅.基于血肌酐和胱抑素C的四个CKD—EPI方程对我国慢性肾脏病患者的适用性研究[J].中华检验医学杂志,2012,35(9):798-804. 被引量:25
  • 6Newman DJ. Cystatin C. Ann Clin Biochem, 2002, 39: 89-104.
  • 7Grubb A, Blirup-Jensen S, Lindstrrm V, et al. First certified reference material for cystatin C in human serum ERM-DA471/ IFCC. Clin Chem Lab Med, 2010, 48: 1619-1621.
  • 8Institute for Reference Materials and Measurements, Joint Research Centre, European Commission. Certification of cystatin C in the human serum reference material ERM-DA471/IFCC. Clin Chem Lab Med. 2010.48: 1619-1621.
  • 9国家标准物质研究中心.JJGl006-1994.一级标准物质技术规范.北京:中国计量出版社,1994.
  • 10国家标准化管理委员会.GB/T15000.3-2008/IS0Guide35.2006标准样品工作导则(3)标准样品定值的一般原则和统计方法.北京:中国标注出版社,2008.

二级参考文献48

  • 1崔蒙,刘加芳,杨清萍,徐金英,刘建迪.高血压病患者血清半胱氨酸蛋白酶抑制剂C测定的临床意义[J].浙江医学,2006,28(5):334-335. 被引量:6
  • 2Li Y, Wang JG, Dolan E, et al. Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension, 2006,47:359-364.
  • 3Kazama JJ, Kutsuwada K, Ataka K, et al. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron,2002,91 : 13-20.
  • 4Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med,2005,352 : 2049 -2060.
  • 5Shlipak MG, Katz R, Fried LF, et al. Cystatin-C and mortality in elderly persons with heart failure. J Am Coil Cardiol, 2005,45 : 268 -271.
  • 6Cockcroft DW, Gault MH. Prediction of creatintine clearance from serum reatintine. Nephron, 1976,16:31-41.
  • 7Kikuya M, Staessen JA, Ohkubo T, et al. Ambulatory arterial stiffness index and 24-hour ambulatory pulse pressure as predictors of mortality in Ohasama, Japan. Stroke,2007,38 : 1161-1166.
  • 8Hansen TW, Staessen JA, Torp-Pedersen C, et al. Ambulatory arterial stiffness index predicts stroke in a general population. J Hypertens, 2006,24 : 2247 -2253.
  • 9Ratto E, Leoncini G, Viazzi F, et al. Ambulatory arterial stiffness index and renal abnormalities in primary hypertension. J Hypertens, 2006,24 : 2033 -2038.
  • 10Robles NR, Mena C, Macias R, et al. Symmetrical ambulatory arterial stiffness index: relationship with microalbuminuria and renal function. Eur JIntern Med ,2010,21 : 118-122.

共引文献35

同被引文献13

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部